BG Medicine Announces Fiscal 2011 Second Quarter Results
August 11, 2011 08:00 ET
|
BG Medicine Inc.
WALTHAM, Mass., Aug. 11, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced its consolidated results of operations for the three and six months ended June 30, 2011, and provided...
New Studies on Role of Galectin-3 in Heart Failure to be Presented at European Society of Cardiology (ESC) Congress 2011
August 02, 2011 08:30 ET
|
BG Medicine Inc.
WALTHAM, Mass., Aug. 2, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today that...
BG Medicine, Inc. Announces Peer-Reviewed Publication on High-Risk Plaque (HRP) Initiative and BioImage Study
August 01, 2011 16:30 ET
|
BG Medicine Inc.
WALTHAM, Mass., Aug. 1, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today the...
BG Medicine, Inc. to Present at the Leerink Swann Life Science Tools & Diagnostics Roundtable
August 01, 2011 08:00 ET
|
BG Medicine Inc.
WALTHAM, Mass., Aug. 1, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today that...
BG Medicine Announces Second Quarter 2011 Financial Results Release Date and Conference Call Information and Automatic Extension of IPO Lock-Up Agreements
July 28, 2011 08:00 ET
|
BG Medicine Inc.
WALTHAM, Mass., July 28, 2011 (GLOBE NEWSWIRE) -- BG Medicine Inc. (Nasdaq:BGMD) today announced that its financial results for the second quarter of fiscal year 2011 will be released prior to the...
BG Medicine, Inc. Appoints Stephane Bancel as Executive Chairman of the Board
July 27, 2011 08:00 ET
|
BG Medicine Inc.
WALTHAM, Mass., July 27, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today...
BG Medicine Inc. Receives ISO 13485 Certification
July 18, 2011 16:30 ET
|
BG Medicine Inc.
WALTHAM, Mass., July 18, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today...
BG Medicine, Inc. Names Stephen R. Miller Chief Commercial Officer
June 28, 2011 08:30 ET
|
BG Medicine Inc.
WALTHAM, Mass., June 28, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a life sciences company focused on the discovery, development, and commercialization of novel, biomarker-based...
BG Medicine to Present at the Jefferies 2011 Global Healthcare Conference
June 03, 2011 17:00 ET
|
BG Medicine Inc.
WALTHAM, Mass., June 3, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) announced today that it will present at the Jefferies 2011 Global Healthcare Conference on Wednesday, June 8, 2011 at...
BG Medicine Announces Fiscal 2011 First Quarter Results
May 12, 2011 07:00 ET
|
BG Medicine Inc.
WALTHAM, Mass., May 12, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced its consolidated results of operations for the first quarter of fiscal year 2011 and provided a...